LONDON, GREATER LONDON, UNITED KINGDOM, March 26, 2025 /EINPresswire / -- The year 2024 saw the cholinesterase ChE inhibitors market size at a whopping $3.92 billion, and this impressive figure is ...

“Physicians may prescribe immunosuppressants such as calcineurin inhibitors, but their long ... “To address the unmet needs in CHE treatment, further research and clinical trials that focus ...

An approval would make the topical JAK inhibitor the first therapeutic specifically greenlit for CHE in the U.S.; the cream has already been approved in Europe, where it’s now sold as Anzupgo.